Core Insights - TOMI Environmental Solutions, Inc. reported financial results for the year ended December 31, 2025, highlighting strategic initiatives aimed at long-term growth [1] Financial Results - Sales for 2025 were $5,636,000, a decrease from $7,739,000 in 2024, attributed to customers deferring capital expenditures due to economic uncertainties [5] - Gross profit margin remained strong at approximately 55%, indicating operational efficiency [5] - Operating loss was ($3,854,000) for 2025, compared to a loss of ($4,105,000) in 2024 [5] - Net loss for 2025 was $(3,749,000) or $(0.19) per share, an improvement from a net loss of $(4,477,000) or $(0.22) per share in 2024 [5][25] - Cash and cash equivalents as of December 31, 2025, were $88,000, with working capital of $1.0 million [8] Recent Business Highlights - The company strengthened government relationships, notably being selected by NASA for a biosecurity operation [5] - New customer acquisitions included global CDMOs and prestigious university research groups [5] - Regulatory developments in the food market have expanded applications for SteraMist iHP, particularly in food safety [5] - International revenue increased to approximately 29% of total revenue, up from 21% in the previous year [5] Operational Efficiencies - Total operating expenses were reduced by approximately 10% in 2025 [5] - The company is exploring AI-related technologies to enhance operational efficiency [5] Product Innovation - Continued investment in R&D to expand SteraMist® applications across various sectors, resulting in a more comprehensive product portfolio [5] - SteraMist was recognized as the Disinfection and Decontamination Products Company of the Year 2025 by MedTech Outlook [5] Strategic Validation - A USDA study confirmed the efficacy of BIT against deformed wing virus for agricultural biosecurity in honeybees [5] Liquidity and Capital Access - The company completed a $535,000 convertible note financing to support growth initiatives [8] - An equity line of credit allows the company to sell up to $20,000,000 in common stock over a 24-month period [8] Market Opportunities - The food safety market is projected to grow from $28 million in 2025 to $31 million in 2026 [9] - The global medical device sterilization market is valued at $5.29 billion [10] - The company aims to penetrate the biofuel market and enhance domestic energy security [10] Looking Ahead - The company enters 2026 with strong operational momentum and a sales pipeline valued at $16 million for integration projects and $20 million for SteraMist iHP [11] - Focus on clean manufacturing, AI-enabled automation, and biosecurity to drive sustainable long-term growth [11]

Core Insights - TOMI Environmental Solutions, Inc. is expanding its presence in Canada through strategic placements of its SteraMist iHP technology in major healthcare and research facilities, indicating a growing adoption of advanced disinfection solutions in critical environments [1][2][4] Group 1: Company Expansion - The integration of SteraMist technology into Canada's largest health research organization marks a significant milestone for TOMI, enhancing biosafety standards in national health research [2] - Successful deployments of SteraMist technology have occurred at a prominent trauma center in Nova Scotia and a research university, showcasing its effectiveness in rapid-response scenarios [2][4] - TOMI's Canadian distribution partner has increased equipment inventory to support direct-to-customer sales, aligning with a pipeline of competitive bids for potential purchases in the current fiscal year [3] Group 2: Technology and Solutions - SteraMist iHP technology is positioned as the gold standard for pathogen control in regulated healthcare and research environments, reinforcing TOMI's commitment to advanced decontamination solutions [4] - The technology utilizes a low percentage of Hydrogen Peroxide to create a fog of ionized Hydrogen Peroxide (iHP), which effectively kills germs without being caustic [5] Group 3: Market and Industry Context - TOMI's products are designed for a wide range of commercial structures, including hospitals, schools, and military facilities, indicating a broad market application for its disinfection solutions [6] - The company is actively involved in developing training programs and application protocols, ensuring that clients are well-equipped to utilize its technology effectively [7]

Core Insights - TOMI Environmental Solutions, Inc. has formed a strategic partnership with Total Clean Air, designating TCA as its Preferred European Partner for SteraMist iHP decontamination technology [1][2] Company Overview - TOMI is a global leader in disinfection and decontamination solutions, utilizing its Binary Ionization Technology (BIT) platform to produce a germ-killing aerosol [6] - TCA specializes in cleanroom design, build, and validation, operating across pharmaceutical, life sciences, and healthcare sectors [9] Partnership Details - TCA will handle sales, service, and technical support for TOMI's SteraMist iHP across the UK and EU, addressing the growing demand for aseptic processing and high-level decontamination [2][3] - The UK infection control market is projected to exceed $6 billion by 2031, indicating significant growth potential for both companies [2] Market Dynamics - The UK sterility testing market is expected to grow at a 14% CAGR through 2035, driven by regulatory requirements and a shift towards rapid testing methods [3] - The partnership aims to enhance compliance with EU GMP Annex 1, providing in-region technical support and validation [3] Service Infrastructure - TCA will maintain consignment stock of SteraMist iHP equipment and consumables, offering annual calibration and routine inspections to ensure high-quality service [4] - A demonstration and trial program will be established at TCA's UK showroom, allowing hands-on evaluation of SteraMist equipment [5]

Core Insights - TOMI Environmental Solutions, Inc. has announced the purchase of its SteraMist Hybrid System for a private research university on the East Coast, aimed at ensuring the safety and sterilization of reusable medical equipment for patient homes [1] - The facility requires a reliable decontamination solution for its sterilization room, which is crucial for meeting safety protocols for reusable medical products [2] - The integration of the SteraMist Hybrid System demonstrates its capability to meet the high standards set by healthcare organizations, marking the second sale in a $13 million pipeline for automated installation projects [3] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, utilizing its Binary Ionization Technology® (BIT™) platform to provide indoor surface disinfection solutions [4] - The BIT™ solution, developed under a defense grant with DARPA, uses a low percentage of Hydrogen Peroxide to create a fog of ionized Hydrogen Peroxide (iHP™), which effectively kills germs [4] - TOMI's products cater to a wide range of commercial structures, including hospitals, schools, and military facilities, as well as residential applications [5] Industry Context - The demand for reliable decontamination solutions is critical in the healthcare sector, particularly for medical devices and products that are reprocessed for patient use [2] - The successful deployment of the SteraMist Hybrid System at a research university highlights the increasing need for advanced sterilization technologies in high-stakes medical environments [3]

Core Viewpoint - TOMI Environmental Solutions, Inc. advocates for cruise lines to adopt hospital-grade disinfection technologies like SteraMist to enhance maritime decontamination standards and protect passengers and crew from health outbreaks [1][2][3] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, utilizing its proprietary Binary Ionization Technology® (BIT™) platform to provide effective indoor surface disinfection solutions [4][5] - The BIT™ solution, developed under a defense grant with DARPA, employs a low percentage of Hydrogen Peroxide to create a fog of ionized Hydrogen Peroxide (iHP™), which acts as a germ-killing aerosol [4] Industry Context - The cruise industry is identified as a high-risk environment for health outbreaks due to close quarters and shared facilities, necessitating advanced disinfection methods to prevent the spread of pathogens like Norovirus and Legionella [2][3] - Recent incidents, such as a Norovirus outbreak affecting over 100 passengers on an AIDA Cruises vessel, highlight the urgent need for improved decontamination practices within the cruise sector [2] Product Application - SteraMist is positioned as a proactive solution for critical areas on cruise ships, including dining and entertainment spaces, crew health areas, and children's facilities, which are often neglected by traditional cleaning methods [2][3] - The technology allows for rapid and thorough disinfection, minimizing downtime and effectively containing potential outbreaks [2][3] Market Opportunity - The adoption of SteraMist is presented as a value proposition for cruise lines, promising increased passenger confidence, reduced operational risks from outbreaks, and a competitive marketing advantage [3] - The company encourages collaboration with the cruise industry and the public to promote the global adoption of enhanced disinfection technologies [3]

Core Insights - TOMI Environmental Solutions, Inc. has made significant progress in its custom integration pipeline, valued at approximately $3 million, indicating strong momentum in the life sciences sector [1][6] - The company is strategically positioned as a turnkey solution provider in regulated industries, focusing on disinfection and decontamination solutions that are highly valued [2][7] Project Pipeline and Business Development - TOMI currently has ten active projects across its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms, catering to both new and existing customers [1][5] - Several projects are expected to be completed by the end of the year, with additional initiatives in the procurement and planning stages, suggesting sustained business development into 2026 [5][10] Strategic Partnerships - The company's success is attributed to strategic partnerships with major enclosure manufacturers such as ESCO Micro Pte. Ltd., Steelco S.p.A., and others, which enhance TOMI's role as a bridge between advanced technology and practical application [3][4] - These partnerships facilitate the seamless integration of TOMI's iHP technology into existing systems, addressing market demand for comprehensive decontamination solutions [4][9] Market Positioning - TOMI focuses on serving the life science and medical device sectors, where contamination control is critical for product quality and patient safety [7][12] - The SIS and CES platforms offer customization capabilities to meet unique operational requirements, positioning TOMI as a strategic partner rather than just an equipment supplier [8][12] Long-term Growth Strategy - The company's emphasis on high-value partnerships in specialized sectors reflects a business model aimed at sustainable expansion rather than rapid volume growth [12] - By leveraging established manufacturer relationships, TOMI enhances its market presence and ensures customers receive integrated solutions with comprehensive support [9][12]

Core Viewpoint - TOMI Environmental Solutions, Inc. has filed a $50 million universal shelf registration statement with the SEC to enhance its financial flexibility for operational growth and strategic initiatives [1][2]. Financial Strategy - The registration statement will allow TOMI to offer and sell securities as needed, providing the company with the ability to efficiently access capital [2]. - TOMI has entered into a strategic advisory and placement arrangement with Bancroft Capital and established an equity line of credit (ELOC) facility with Hudson Global Ventures, allowing the sale of up to $20 million of common stock over a 24-month period [3]. Operational Performance - The CEO of TOMI highlighted strong sequential revenue growth and improved gross margins in Q3, indicating expanding customer adoption of the SteraMist® technology [4]. - The financing from the ELOC is intended to accelerate investments in innovation, manufacturing efficiency, and global distribution [4]. Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology® (BIT™) platform, which utilizes a low percentage of Hydrogen Peroxide to create a germ-killing aerosol [5]. - The company's products are designed for a wide range of commercial structures, including hospitals, cruise ships, schools, and military facilities [6].

Core Insights - TOMI Environmental Solutions, Inc. reported a significant sequential revenue increase of 95% in Q3 2025, driven by higher equipment purchases and strong recurring sales of its BIT™ Solution [5][10] - The company is strategically positioned for long-term growth, with ongoing investments in R&D and expanding international market penetration [10][11] Financial Performance - Revenues for Q3 2025 were $2.0 million, a 95% increase from Q2 2025, but a decrease from $2.54 million in Q3 2024 [5][25] - Gross profit margin remained stable at 61% for Q3 2025, indicating operational efficiency [5][25] - Operating loss for Q3 2025 was $(321,000), compared to an operating income of $149,000 in Q3 2024 [5][25] - Net loss for Q3 2025 was $(450,000) or $(0.02) per share, compared to a net income of $59,000 or $0.00 per share in Q3 2024 [5][25] Business Highlights - The company achieved a 21% year-over-year increase in SteraMist solution sales for the nine months ended September 30, 2025 [5] - International revenue accounted for nearly 36% of Q3 revenue, up from 20% in Q2 2025, reflecting successful global market penetration [5] - The sales order backlog grew to $0.9 million at quarter-end and expanded to $1.3 million by October 31, with approximately $3 million in pending contracts expected to close before year-end [5] Strategic Initiatives - The company is focusing on expanding its product applications across various sectors, including life sciences, healthcare, food safety, and commercial markets [5][10] - A new equity line of credit allows the company to sell up to $20 million in common stock over a 24-month period, enhancing financial flexibility [8][9] - The FDA's expanded approval for hydrogen peroxide use is expected to broaden the application of SteraMist iHP technology, targeting food, agriculture, and environmental biosecurity markets [10][12] Liquidity and Capital Access - As of September 30, 2025, the company had working capital of $2.5 million, with cash used in operations improving by approximately $876,000 compared to the same period in 2024 [7] - The company completed a $535,000 convertible note financing to support growth initiatives [7] Executive Commentary - The CEO highlighted the strong revenue growth and new customer partnerships as evidence of the effectiveness of the company's strategy and execution [10] - The company is optimistic about maintaining momentum into Q4 2025 and throughout 2026, supported by a growing customer base and expanding sales [11][12]

Core Insights - TOMI Environmental Solutions, Inc. is actively participating in the AALAS 76th National Meeting to enhance its presence in the animal research sector [1][2] - The event serves as a platform for TOMI to strengthen strategic partnerships and promote its SteraMist Integrated System (SIS) [2][3] - The company aims to leverage high-impact networking opportunities to drive the adoption of its innovative ionized Hydrogen Peroxide (iHP) technology [3][4] Company Overview - TOMI specializes in disinfection and decontamination solutions, utilizing its Binary Ionization Technology® (BIT™) platform, which is based on low percentage hydrogen peroxide [5] - The company’s products are designed for a wide range of applications, including hospitals, biosafety labs, and food processing facilities [5] Event Participation - AALAS is a significant event for TOMI, attracting thousands of professionals from research institutions, which facilitates lead generation and collaboration [3] - The executive team, including key leaders from various departments, will represent TOMI at the event, highlighting the company's commitment to innovation and customer-centric growth [4][5]

Core Insights - TOMI Environmental Solutions, Inc. has successfully implemented its SteraMist technology at Algafeed, addressing contamination issues in microalgae production for aquaculture [1][2] - Algafeed faced significant Protozoan ciliate contamination, which was effectively reduced through the use of SteraMist, allowing for improved production volumes [2][4] - The partnership between TOMI and Algafeed highlights the versatility of SteraMist technology in various industries, particularly in aquaculture [4] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its Binary Ionization Technology® (BIT™) platform, which employs a low percentage of hydrogen peroxide as the active ingredient [5] - The company’s products are designed for a wide range of applications, including hospitals, pharmaceutical facilities, schools, and food processing facilities [5] Industry Context - Algae serves as a primary food source in aquaculture, and Algafeed's innovative technology allows for high-density microalgae cultivation, providing a competitive edge in the industry [3] - The successful application of SteraMist technology in the aquaculture sector demonstrates the growing importance of effective disinfection solutions in maintaining production efficiency [2][4]